AKT1 and Insulin resistance: In the context of hepatic insulin resistance, it was shown that ceramide can either activate PKCζ and block protein kinase B (AKT) from participating insulin-mediated signaling, or activate protein phosphatase 2A, which is responsible for the dephosphorylation and thus inactivation of AKT (99, 100).